Clinical Trial: Early Access Program for ALXN1840 in Patients With Wilson Disease
Study Type: Expanded Access
Brief Summary:
This is an open-label, single-arm, multi-center EAP, designed to provide early access to ALXN1840 for eligible patients with WD.
Read more